[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100.1K followers Created: 2025-07-24 12:30:11 UTC Swiss drugmaker Novartis will pay up to $X billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases.  XXX engagements  **Related Topics** [drugs](/topic/drugs) [novartis](/topic/novartis) [$novnsw](/topic/$novnsw) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/ReutersLegal/status/1948360059789902163)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Reuters Legal @ReutersLegal on x 100.1K followers
Created: 2025-07-24 12:30:11 UTC
Swiss drugmaker Novartis will pay up to $X billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases.
XXX engagements
Related Topics drugs novartis $novnsw stocks healthcare
/post/tweet::1948360059789902163